Durham, NC, United States of America

Julio Aliberti

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julio Aliberti: Innovator in Autoimmune Disease Treatment

Introduction

Julio Aliberti is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Julio Aliberti holds a patent for "Protozoan derived compositions and methods of use thereof." This invention relates to methods for treating subjects suffering from or susceptible to autoimmune diseases or disorders. The patent outlines the administration of cyclophilin or a biologically active fragment thereof to effectively treat these conditions. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Aliberti works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization allows him to contribute to significant health advancements. His work is crucial in developing therapies that can improve the quality of life for individuals with autoimmune disorders.

Collaborations

Throughout his career, Julio has collaborated with talented individuals such as John Andersen and Hana Golding. These partnerships have fostered an environment of innovation and creativity, leading to impactful advancements in the medical field.

Conclusion

Julio Aliberti's contributions to the treatment of autoimmune diseases through his innovative patent demonstrate his dedication to improving healthcare. His work continues to inspire future advancements in medical research and treatment methodologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…